Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Incidence of cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Sugar EA, Jabs DA, Ahuja A, Thorne JE, Danis RP, Meinert CL; Studies of the Ocular Complications of AIDS Research Group.

Am J Ophthalmol. 2012 Jun;153(6):1016-24.e5. doi: 10.1016/j.ajo.2011.11.014. Epub 2012 Feb 4.

2.

Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment.

Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2007 Apr;114(4):780-6. Epub 2007 Jan 25.

PMID:
17258320
3.

Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.

Jabs DA, Ahuja A, Van Natta M, Lyon A, Srivastava S, Gangaputra S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2010 Nov;117(11):2152-61.e1-2. doi: 10.1016/j.ophtha.2010.03.031. Epub 2010 Jul 29.

4.

Visual field loss in patients with cytomegalovirus retinitis.

Thorne JE, Van Natta ML, Jabs DA, Duncan JL, Srivastava SK; Studies of Ocular Complications of AIDS Research Group.

Ophthalmology. 2011 May;118(5):895-901. doi: 10.1016/j.ophtha.2010.09.017. Epub 2010 Dec 13.

5.

Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.

Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK; Studies of Ocular Complications of AIDS Research Group.

Ophthalmology. 2004 Dec;111(12):2232-9.

PMID:
15582079
6.
7.

Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.

Gangaputra S, Drye L, Vaidya V, Thorne JE, Jabs DA, Lyon AT; Studies of the Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2013 Feb;155(2):206-212.e5. doi: 10.1016/j.ajo.2012.07.019. Epub 2012 Oct 12.

8.

Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.

Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK; Studies of Ocular Complications of AIDS Research Group.

Ophthalmology. 2004 Dec;111(12):2224-31.

PMID:
15582078
9.

Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.

Jabs DA, Ahuja A, Van Natta M, Dunn JP, Yeh S; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2013 Jun;120(6):1262-70. doi: 10.1016/j.ophtha.2012.11.023. Epub 2013 Feb 16.

10.

Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.

Jabs DA, Van Natta ML, Kempen JH, Reed Pavan P, Lim JI, Murphy RL, Hubbard LD.

Am J Ophthalmol. 2002 Jan;133(1):48-61.

PMID:
11755839
11.

Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.

Holbrook JT, Colvin R, van Natta ML, Thorne JE, Bardsley M, Jabs DA; Studies of Ocular Complications of AIDS (SOCA) Research Group.

Am J Ophthalmol. 2011 Oct;152(4):628-637.e1. doi: 10.1016/j.ajo.2011.04.007. Epub 2011 Jul 13.

12.

Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy.

Song MK, Schrier RD, Smith IL, Plummer DJ, Freeman WR.

Retina. 2002 Jun;22(3):262-7.

PMID:
12055457
13.

Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.

Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C; RESTIMOP study team.

AIDS. 2001 Jan 5;15(1):23-31.

PMID:
11192865
14.

Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment.

Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD; Studies of the Ocular Complications of AIDS Research Group.

Ophthalmology. 2007 Apr;114(4):787-93. Epub 2007 Jan 8.

PMID:
17210182
15.
16.

Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).

Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD; Southern California HIV/Eye Consortium.

Am J Ophthalmol. 2008 Jan;145(1):12-22.

PMID:
18154751
17.

Prevalence and clinical management of cytomegalovirus retinitis in AIDS patients in Shanghai, China.

Shi Y, Lu H, He T, Yang Y, Liu L, Zhang R, Zheng Y, Shen Y, Zhang Y, Zhang Z.

BMC Infect Dis. 2011 Nov 24;11:326. doi: 10.1186/1471-2334-11-326.

18.

Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.

Song MK, Azen SP, Buley A, Torriani F, Cheng L, Chaidhawangul S, Ozerdem U, Scholz B, Freeman WR.

Am J Ophthalmol. 2003 Oct;136(4):696-702.

PMID:
14516810
19.
20.

Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.

Karavellas MP, Azen SP, MacDonald JC, Shufelt CL, Lowder CY, Plummer DJ, Glasgow B, Torriani FJ, Freeman WR.

Retina. 2001;21(1):1-9.

PMID:
11217922
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk